Cardinal Health, Inc.
Location
Ohio
Founded
1979-02-28
Website
Risk Signals
3281 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medical, Dental, and Hospital Equipment and Supplies, Drugs, Drug Proprietaries, and Druggists' Sundries, Management Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Cardinal Health, Inc.
Live alerts from global media, monitored by Business Radar
2025-05-06 (pharmaceuticalcommerce.com)
Asembia 2025: Tracking Long-Term Outcomes Key to Advanced Therapy Value
Fran Gregory, VP, emerging therapies, Cardinal Health, emphasizes the need for long-term outcomes tracking and robust health economic modeling to demonstrate the sustained value of advanced therapies and support future payment strategies.
Read more
2025-05-02 (devdiscourse.com)
Global Health Landscape: From Vaccine Innovation to Regulatory Battles | Science-Environment
Recent health news spotlights include Cardinal Health's robust growth forecast despite tariffs, CVS's strategy shifts, Biogen's resilience in rare disease markets, and novel treatments advancements by J&J. Additionally, regulatory and funding challenges faced by WHO and the U.S. emphasize the complex dynamics shaping global healthcare.
Read more
2025-04-25 (globalgrowthinsights.com)
Medical Body Temperature Monitoring Market Size, Share, Growth, and Industry Analysis, By Types (Wired, Wireless), By Applications Covered (Operation Room, ICU), Regional Insights and Forecast to 2033
Medical Body Temperature Monitoring Market size in 2025 is 339.19 M, with projections to grow to 419.77 M by 2033 at a CAGR of 2.70%.
Read more
2025-04-01 (jhconline.com)
Cardinal Health releases new report on the cell and gene therapy industry – The Journal of Healthcare Contracting
May 8, 2025- Cardinal Health released its 2025 Advanced Therapies Report: Revolutionizing patient care – the promise and potential of cell and gene therapies, providing insights into the evolving landscape of cell and gene therapies (CGTs).
Read more
2025-04-01 (jhconline.com)
Cardinal Health recognizes 50th annual Medical Laboratory Professionals Week 2025 – The Journal of Healthcare Contracting
April 22, 2025- For five decades, Medical Laboratory Professionals Week has honored healthcare heroes, according to Cardinal Health. Their contributions continue to grow in scope and significance, shaping the future of healthcare. Every day, laboratory professionals make a profound impact on healthcare through their expertise, innovation, and dedication. Their proficiency in diagnostic testing and disease prevention transforms lives, driving excellence in patient safety, enhancing the quality of care, and optimizing healthcare costs. Every accurate diagnosis and treatment decision is a testament to their skill and commitment.
Read more
2025-03-27 (hubcityspokes.com)
Latino: In wise move, Speaker White sends proposed prescription drug law to conference |
Lawmakers should not ignore the concerns of Mississippi's biggest employers as they wade into a national scrum over PBM reform. House Speaker Jason White announced Wednesday that a bill to regulate pharmacy benefit managers (PBMs) would be sent to conference.
Read more
2025-03-25 (pharmiweb.com)
Disposable Syringes Market Forecast: 6.1% CAGR to Drive Growth to US$ 17,026.2 Million by 2035 – Analysis by TMR -
The global disposable syringes market was valued at US$ 8,819.3 Million in 2024 and is projected to grow at a CAGR of 6.1% from 2025 to 2035, reaching US$ 17,026.2 Million by the end of 2035. This growth is fueled by increasing demand for safe, single-use medical devices, rising global vaccination initiatives, and t...
Read more
2025-03-24 (businesswire.com)
Harrow Announces Transitional Pass-Through Reimbursement Status for TRIESENCE® (Triamcinolone Acetonide Injectable Suspension) 40 mg/mL
Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that the Centers for Medicare & Medicaid Services (CMS) has a...
Read more
2025-02-06 (aacrjournals.org)
High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes | Cancer Discovery | American Association for Cancer Research
Circulating tumor cell (CTC) lineage phenotypes are associated with prognosis in metastatic prostate cancer, and the CTC luminal-B-like phenotype is
Read more
2024-11-12 (modernhealthcare.com)
Cardinal Health to buy GI Alliance, Advanced Diabetes Supply Group |
The healthcare products and services company plans to acquire Advanced Diabetes Supply Group and a majority stake in GI Alliance by early 2025.
Read more
2023-04-14 (redrocknews.com)
Yavapai Board of Supervisors tackles drugs, staffing 5 min read
Law enforcement and public safety was the main topic under discussion at the April 5 meeting of the Yavapai County Board of Supervisors in Prescott. The board made several decisions regarding how it plans to use money from opioid abuse settlements. "It has taken two years for us to begin to receive opioid settlement funds," […]
Read more
2020-05-11 (massdevice.com)
FDA authorizes Quidel antigen test for rapid COVID-19 detection
FDA has issued a first-of-its-kind emergency use authorization for Quidel‘s COVID-19 antigen test, which enables rapid diagnosis of virus infection. San Diego–based Quidel describes the Sofia2 SARS Antigen FIA as a rapid point-of-care test to be used
Read more